Stay updated on Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.2 to v3.6.3, indicating a version bump in the page's content management. This change does not modify study data or public study details.
    Difference
    0.0%
    Check dated 2026-07-06T16:37:57.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2 instead of v3.6.0, indicating a newer revision of the page/document.
    Difference
    0.0%
    Check dated 2026-06-29T08:34:59.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page gains new helper sections for reading the study record, joining the study, and answering common questions, and the recruitment status is updated to indicate no active enrollment; the revision label is updated to v3.6.0 and the Intervention/Treatment heading formatting is adjusted.
    Difference
    0.3%
    Check dated 2026-06-15T08:18:18.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page's revision indicator was updated from v3.5.4 to v3.5.5, marking a new version of the ClinicalTrials.gov study record.
    Difference
    0.0%
    Check dated 2026-06-08T04:18:07.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-17T10:26:59.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting an informational site release rather than a change to the clinical trial content.
    Difference
    0.0%
    Check dated 2026-04-25T18:47:44.000Z thumbnail image

Stay in the know with updates to Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab Long-Term Extension in Psoriatic Arthritis Clinical Trial page.